AAP Releases 2026-27 Influenza Vaccination Recommendations for Children: Key Takeaways for Pediatric Practices

As pediatric practices prepare for the upcoming flu season, the American Academy of Pediatrics (AAP) has released its 2026-27 influenza vaccination recommendations for children. The updated guidance reinforces the importance of annual influenza vaccination and includes expanded recommendations for immunocompromised children. The full policy statement is available on the AAP website.
For pediatric practices, understanding the latest influenza immunization guidance can help improve patient outcomes, strengthen vaccine confidence, and ensure readiness for the 2026-27 influenza season.
AAP Continues to Recommend Annual Flu Vaccination

The AAP recommends annual influenza vaccination for all children ages 6 months and older who do not have a medical contraindication. Any licensed influenza vaccine that is appropriate for a child’s age and health status may be used, with no preference for a specific product or formulation.

For pediatric practices, these recommendations reinforce the importance of discussing influenza vaccination with families and encouraging vaccination as a routine part of preventive care. A strong provider recommendation remains one of the most effective ways to increase vaccination uptake.

Children Should Be Vaccinated Early in the Season

One notable point in this year’s guidance is the timing of vaccination. While adults are generally advised to avoid receiving influenza vaccine too early in July or August, children may be vaccinated as soon as vaccine becomes available, with the goal of completing vaccination by the end of October.

Early vaccination can help ensure children are protected before influenza activity begins to increase in the community and may improve vaccination coverage during the busy fall season.

New Guidance for Immunocompromised Children

The 2026-27 recommendations include expanded guidance for immunocompromised children. The AAP added detailed recommendations to help providers make vaccination decisions for children with moderate or severe immunocompromising conditions, aligning with evidence-based guidance from other leading medical organizations.

Practices caring for medically complex patients may wish to review the full recommendations to ensure vaccination plans reflect the latest guidance.

A Reminder of Why Flu Vaccination Matters

The importance of influenza vaccination remains clear. According to the AAP, the 2025-26 influenza season was severe, resulting in 190 influenza-associated pediatric deaths. Vaccination coverage among children ages 6 months through 17 years was just 49.4%, leaving many children vulnerable to serious illness. Historically, approximately 85% of children who die from influenza have not been vaccinated.

These statistics highlight the critical role healthcare providers play in educating families about the benefits of annual influenza vaccination and helping improve vaccination rates within their communities.

How Pediatric Practices Can Prepare for the 2026-27 Flu Season 

With vaccine shipments arriving and patient demand increasing throughout the fall, now is the time for pediatric practices to prepare. Taking proactive steps can support higher vaccination coverage, improve workflow efficiency, and help ensure patients receive protection before influenza activity peaks.

Practices should consider:

  • Reviewing influenza vaccine inventory needs
  • Planning patient outreach and reminder campaigns
  • Updating staff on current influenza vaccination recommendations
  • Preparing to answer questions about vaccine timing and eligibility
  • Evaluating scheduling workflows to support efficient vaccine administration
How CPP Can support your influenza vaccination strategy 

The 2026-27 influenza vaccination recommendations for children provide important guidance to help pediatric practices protect patients during a potentially challenging flu season. By reviewing inventory needs, educating staff, and promoting timely vaccination, practices can play a critical role in reducing influenza-related illness and complications.

For complete clinical guidance, review the AAP’s Recommendations for Prevention and Control of Influenza in Children, 2026-2027 policy statement.

CPP is here to support your practice throughout influenza season. Whether you have questions about vaccine recommendations, inventory planning, or vaccination strategies, please reach out to our team.

 

 

Related Posts